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Evaluation of 3 
Electronic Methods 
Used to Detect  
Influenza Diagnoses 
during 2009  
Pandemic
To the Editor: Conducting in-
fluenza surveillance in hospitals is 
imperative to detect outbreaks, in-
form infection control policy, and 
allocate resources (1). Hospital ad-
ministrative data could be harnessed 
for this purpose (2,3) but are not 
currently used for infection surveil-
lance because of data lag times. In-
fluenza cases could be identified by 
using International Classification of 
Diseases, Tenth Revision, Clinical 
Modification (ICD-10-CM), codes 
within the discharge abstract, phar-
macy, and microbiology labora-
tory information systems. Although 
these approaches are assumed to 
accurately identify influenza cases, 
this assumption has not been widely 
tested, especially during a pandemic. 
In this retrospective cohort study, 
we aimed to identify and evaluate 3 
electronic methods of influenza case 
detection during 1 peak of influenza 
A(H1N1)pdm09.
With ethics board approval, we 
used the Ottawa Hospital Data Ware-
house (OHDW) (Ottawa, ON, Can-
ada) to identify 398 adult inpatients 
at the Ottawa Hospital during Octo-
ber–December 2009 who had cardi-
ac, infectious, or respiratory disease 
diagnoses (ICD-10-CM codes: all J 
codes, A15–19, A37, A40, A41, A49, 
I26, I28, I50, I51.4, R57). OHDW 
is a relational database containing 
pharmacy, laboratory, and discharge 
diagnosis information for inpatients 
at Ottawa Hospital. We detected in-
fluenza in the following ways: influ-
enza diagnosis in the discharge ab-
stract database (DAD) (ICD-10-CM 
codes J09–J11); prescription for an 
antiviral drug (oseltamivir, zanami-
vir) in the pharmacy system; and a 
positive laboratory test during the hos-
pital encounter (without specifying 
test type or specimen) in the labora-
tory system.
We assessed these case defini-
tions against a criterion standard of 
influenza diagnosis on the hospital 
chart, determined by a physician 
reviewer blinded to the electronic 
values for the case definitions. We 
constructed 2 × 2 contingency ta-
bles for each classification method 
and calculated sensitivity, specific-
ity, positive predictive value (PPV), 
and likelihood ratios using standard 
equations.
Influenza prevalence in this co-
hort was 13.6% (54/398) by our crite-
rion standard. The proportion of male 
and female patients was equal, with a 
median age of 69 years (interquartile 
range 53–81 years). Median length of 
hospital stay was 6 days (interquar-
tile range 1–12 days). A total of 77 
(19.3%) patients were admitted to the 
intensive care unit, and 51 (12.8%) 
patients died in hospital. Two (0.5%) 
patients died with a primary diag-
nosis of influenza. The Table shows 
the performance characteristics of 
each influenza classification method 
against the criterion standard. The 
DAD-based influenza diagnosis al-
gorithm was most accurate, with 
sensitivity of 90.7% (95% CI 79.7%–
96.9%), specificity of 96.5% (95% CI 
94%–98.2%), and PPV of 80.3%.
Our results demonstrate ad-
equate correlation between ICD-10-
CM coding for influenza in adults 
during a 3-month peak of the pan-
demic season within a single institu-
tion. Coding or interpretative errors 
were the probable cause of the 10% 
false-negative and 3% false-positive 
rates of ICD-10 coding for influenza 
on the DAD.
Classifying influenza by anti-
viral prescription was sensitive but 
less specific than clinical diagnosis. 
This finding could be explained by 
empiric antiviral prescriptions for 
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infectious respiratory symptoms 
being written before confirmatory 
testing (4). Influenza classification 
by positive laboratory tests was spe-
cific but less sensitive in this analy-
sis, probably because of nonuniform 
laboratory testing among inpatients 
from lack of specific criteria to guide 
testing and lack of testing in those 
with less severe illness. Not all pa-
tients who have influenza are tested 
for it, and these diagnoses would be 
classed as false negatives, influenc-
ing the sensitivity downward. Fur-
thermore, laboratory testing would 
be likely to miss patients with in-
fluenza-triggered exacerbations of 
congestive heart failure and chronic 
obstructive pulmonary disease (5), 
which would underestimate influ-
enza cases.
Our study correlated ICD-10-
CM–specific codes for influenza in 
hospitalized adults during 1 peak of 
the 2009 influenza pandemic. A previ-
ous study in the United States in 2006 
evaluated ICD-9-CM admission and 
discharge influenza codes in hospital-
ized children (6). The authors found 
that of 715 laboratory-confirmed in-
fluenza cases, ICD-9-CM codes were 
only 65% sensitive, suggesting that 
use of these codes for surveillance 
would underestimate influenza hos-
pitalizations by 35% (6). This work 
was undertaken in 3 consecutive non-
pandemic influenza seasons during 
2001–2004.
Our findings must be general-
ized with caution because our study 
evaluated ICD-10-CM coding ac-
curacy over 3 months of a pandemic 
influenza season in adults at 1 aca-
demic hospital. With lower influenza 
prevalence, the PPV would drop, 
suggesting that the coded diagnosis 
would overestimate influenza hospi-
talizations. Furthermore, sensitivity 
and specificity of codes might not be 
static measures because the diagnosis 
of influenza on the chart might be in-
fluenced by the prevalence of influ-
enza in communities (7).
Given these limitations, further 
work is needed to fully validate ICD-
10 codes for influenza during seasons 
of low prevalence and in other popu-
lations including children. Despite 
this, our results have implications for 
future research using administrative 
data to develop timely surveillance 
systems, track costs, and monitor re-
source use.
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Table.	Performance	characteristics	of	electronic	influenza	classification	methods	compared	to	criterion	standard	chart	review, Ottawa	
Hospital,	Ottawa,	Ontario,	Canada,	October–December	2009* 
Method 
No.  %	(95%	CI)  %  %	(95%	CI) 
TP FP TN FN  Sensitivity Specificity  PPV NPV  PLR NLR 
DAD	flu	diagnosis 49 12 332 5  90.7	 
(79.7–96.9) 
96.5	 
(94–98.2) 
 80.3 98.5  26	 
(14.9–45.7) 
0.10	 
(0.04–0.22) 
Positive	laboratory	
result 
43 7 337 11  79.7	 
(66.5–89.4) 
98	 
(95.9–99.2) 
 86.0 96.8  39.1	 
(18.6–82.5) 
0.21	 
(0.12–0.35) 
Antiviral	drug	
prescribed 
51 83 261 3  94.4	 
(84.6–98.8) 
75.9	 
(71–80.3) 
 38.0 98.8  3.9	 
(3.2–4.8) 
0.07	 
(0.02–0.22) 
*TP,	true	positive;	FP,	false	positive;	TN,	true	negative:	FN,	false	negative;	PPV,	positive	predictive	value;	NPV,	negative	predictive	value;	PLR,	positive	
likelihood	ratio;	NLR,	negative	likelihood	ratio;	DAD	Flu	Diagnosis, International	Classification	of	Diseases,	Tenth	Revision,	Clinical	Modification,	
diagnosis	code	for	influenza	on	the	discharge	abstract	database	stored	in	the	Ottawa	Hospital	Data	Warehouse. 
 
